Cargando…

Early myocardial oedema can predict subsequent cardiomyopathy in high‐dose anthracycline therapy

AIMS: This study aims to assess subclinical changes in functional and morphologic myocardial MR parameters very early into a repetitive high‐dose anthracycline treatment (planned cumulative dose >650 mg/m(2)), which may predict subsequent development of anthracycline‐induced cardiomyopathy (aCMP)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muehlberg, Fabian, Kornfeld, Markus, Zange, Leonora, Ghani, Saeed, Reichardt, Annette, Reichardt, Peter, Schulz‐Menger, Jeanette
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871709/ https://www.ncbi.nlm.nih.gov/pubmed/36404640 http://dx.doi.org/10.1002/ehf2.14232

Ejemplares similares

Native myocardial T1 time can predict development of subsequent anthracycline‐induced cardiomyopathy
por: Muehlberg, Fabian, et al.
Publicado: (2018)

Quantification in cardiovascular magnetic resonance: agreement of software from three different vendors on assessment of left ventricular function, 2D flow and parametric mapping
por: Zange, Leonora, et al.
Publicado: (2019)

Comparison of fast multi-slice and standard segmented techniques for detection of late gadolinium enhancement in ischemic and non-ischemic cardiomyopathy – a prospective clinical cardiovascular magnetic resonance trial
por: Muehlberg, Fabian, et al.
Publicado: (2018)

Characterization of critically ill patients with septic shock and sepsis‐associated cardiomyopathy using cardiovascular MRI
por: Muehlberg, Fabian, et al.
Publicado: (2022)

Pregnancy and Cardiomyopathy After Anthracyclines in Childhood
por: Thompson, Kara Annette
Publicado: (2018)

A multi-center cardiovascular magnetic resonance network for tele-training, tele-supervision and knowledge sharing
por: Muehlberg, Fabian, et al.
Publicado: (2015)

Equivalence of conventional and fast late gadolinium enhancement (LGE) techniques for quantitative evaluation of fibrosis in ischemic and non-ischemic cardiac disease - Save the Time!
por: Muehlberg, Fabian, et al.
Publicado: (2016)

Translating principles of quality control to cardiovascular magnetic resonance: assessing quantitative parameters of the left ventricle in a large cohort
por: Riazy, Leili, et al.
Publicado: (2023)

Myocardial oedema in the setting of immersion pulmonary oedema - Cause or effect?
por: Oldman, James, et al.
Publicado: (2023)

The role of motivated science reception and numeracy in the context of the COVID-19 pandemic
por: Hutmacher, Fabian, et al.
Publicado: (2021)

Comparison of Gadopentetate dimeglumine and Gadobenate dimeglumine in depiction of non-ischemic fibrosis in hypertrophic cardiomyopathy
por: Rudolph, Andre, et al.
Publicado: (2009)

Embolic myocardial infarctions look different: a comparison of experimental and fateful embolic lesions
por: Wassmuth, Ralf, et al.
Publicado: (2011)

Potential genetic predisposition for anthracycline-associated cardiomyopathy in families with dilated cardiomyopathy
por: Wasielewski, Marijke, et al.
Publicado: (2014)

The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
por: Watanabe, Kenichi, et al.
Publicado: (2011)

Electrocardiograms for cardiomyopathy risk stratification in children with anthracycline exposure
por: Desai, Lajja, et al.
Publicado: (2019)

Myeloperoxidase is a critical mediator of anthracycline-induced cardiomyopathy
por: Nettersheim, Felix Sebastian, et al.
Publicado: (2023)

Efficacy and safety of Dexrazoxane (DRZ) in sarcoma patients receiving high cumulative doses of anthracycline therapy – a retrospective study including 32 patients
por: Schuler, Markus K., et al.
Publicado: (2016)

Z-score mapping for standardized analysis and reporting of cardiovascular magnetic resonance modified Look-Locker inversion recovery (MOLLI) T1 data: Normal behavior and validation in patients with amyloidosis
por: Kranzusch, Riccardo, et al.
Publicado: (2020)

T2-mapping in normal volunteers compared to patients with edema reveals wide range of myocardial T2 in female volunteers
por: Wassmuth, Ralf, et al.
Publicado: (2012)

Anthracycline-induced cardiomyopathy: Is there a new light at the end of the tunnel?
por: Fradley, Michael G., et al.
Publicado: (2021)

Genetic Testing in Evaluating Risk of Anthracycline Cardiomyopathy: Are We There Yet?
por: Wong-Siegel, Jeannette R., et al.
Publicado: (2023)

New "gold standard" for assessing myocardial oedema in STEMI?
por: McAlindon, Elisa, et al.
Publicado: (2013)

Evaluation of 7 techniques for the quantification of myocardial oedema in STEMI
por: McAlindon, Elisa, et al.
Publicado: (2013)

Myocardial oedema: pathophysiological basis and implications for the failing heart
por: Vasques‐Nóvoa, Francisco, et al.
Publicado: (2022)

Recovery of regional myocardial function and myocardial oedema following reperfused acute myocardial infarction
por: Kidambi, Ananth, et al.
Publicado: (2012)

Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer
por: Wang, Yuehan, et al.
Publicado: (2023)

Detection of myocardial oedema with the use of diffusion-weighted imaging in acute myocardial infarction
por: Kociemba, Anna, et al.
Publicado: (2011)

Molecular pathogenetic mechanisms and new therapeutic perspectives in anthracycline-induced cardiomyopathy
por: Distefano, Giuseppe
Publicado: (2009)

Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines
por: Tagawa, Michihito, et al.
Publicado: (2021)

Takotsubo cardiomyopathy precipitated by negative pressure pulmonary oedema following total thyroidectomy
por: Bharathi, KS, et al.
Publicado: (2016)

Relation between myocardial edema and myocardial mass during the acute and convalescent phase of myocarditis – a CMR study
por: Zagrosek, Anja, et al.
Publicado: (2008)

A Poroelastic Approach for Modelling Myocardial Oedema in Acute Myocarditis
por: Lourenço, Wesley de Jesus, et al.
Publicado: (2022)

Myocardial Effective Transverse Relaxation Time T(2)(*) is Elevated in Hypertrophic Cardiomyopathy: A 7.0 T Magnetic Resonance Imaging Study
por: Huelnhagen, Till, et al.
Publicado: (2018)

A case series about the favorable effects of sacubitril/valsartan on anthracycline cardiomyopathy
por: De Vecchis, Renato, et al.
Publicado: (2020)

Anthracycline Cardiotoxicity: Can CT Move Us Further?
por: Campia, Umberto, et al.
Publicado: (2020)

The Subtype Identity of Testicular Cancer Cells Determines Their Immunostimulatory Activity in a Coculture Model
por: Gayer, Fabian A., et al.
Publicado: (2023)

Chronic Anthracycline-related Myocarditis Presenting as Diffuse Myocardial Calcification
por: Pejic, Marijan, et al.
Publicado: (2019)

Anthracyclines and Biomarkers of Myocardial Injury: The Effect of Remote Ischemic Conditioning
por: Mallouppas, Michael, et al.
Publicado: (2023)

Left ventricular remodelling post-myocardial infarction: pathophysiology, imaging, and novel therapies
por: Frantz, Stefan, et al.
Publicado: (2022)

Acoustics dictionary: quadrilingual English, German, French, Dutch
por: Reichardt, Walter
Publicado: (1983)

Cannot write session to /tmp/vufind_sessions/sess_tcrk6tjuodoi9gr5mrm3aivdmp